Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -2 of 2 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 8/5/2008 First Published: 6/23/2003


1.		Phase II Randomized Study of Topical Halofuginone Hydrobromide in Patients With HIV-Related Kaposi's Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				16 and over				NCI				AMC-036 CWRU-040332, NCT00064142

Last Modified: 4/13/2004 First Published: 12/1/2001


2.		Phase I Study of Halofuginone Hydrobromide in Patients With Progressive Advanced Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				Pharmaceutical / Industry				EORTC-16007 COLLGARD-EORTC-16007, NCT00027677

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute